Company page
Hansa Biopharma Ab
Hansa Biopharma AB, traded under the ticker HNSA, is a public company based in Sweden with a market capitalization of approximately 319 million USD. The company focuses on developing innovative therapies for patients with rare immunological conditions. Hansa Biopharma aims to address unmet medical needs through its cutting-edge research and development efforts.
- Ticker
- HNSA:OMXSTO
- Asset type
- Stock
- Market cap
- $470.7M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- OMXSTO
- Currency
- SEK